We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.50
Bid: 92.00
Ask: 97.00
Change: -0.50 (-0.53%)
Spread: 5.00 (5.435%)
Open: 95.00
High: 95.00
Low: 94.50
Prev. Close: 95.00
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement & Trading Update

29 Nov 2023 07:00

RNS Number : 9790U
Transense Technologies PLC
29 November 2023
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Transense Technologies plc

("Transense", or "the Company")

 

AGM Statement and Trading Update

Transense Technologies plc, the provider of specialist sensing solutions and measurement systems, announces the following trading update for the first four months of the financial year to 30 June 2024 (the "Period") ahead of its Annual General Meeting to be held at 10:00 a.m. today.

Trading Update

Revenues in the Period were 13 per cent higher than in the comparable period last year. The unaudited profit before taxation increased threefold on that generated in the comparable period, assisted by a temporary reduction in operating costs following the team reorganisation.

Although well ahead of the prior period, revenue in the Period was below the Board's expectations. Royalty income from iTrack continued to rise, although more slowly than the historic run rate. Revenues from Translogik and SAWsense were substantially unchanged from the prior period, with a return to strong growth expected towards the second half of the financial year. The short-term order book and opportunity pipeline for both SAWsense and Translogik indicate an upturn in trading, and therefore the Board expects to meet market expectations for the full year.

Operating cashflow is robust, and the net cash balance at 31 October 2023, following the receipt of Q1 iTrack royalties, was approximately £1.72m (30 June 2023: £0.98m).

To drive further revenue growth, market awareness, and accelerate pipeline conversion across its divisions, the Company is actively recruiting. An additional senior mechanical engineer joined this month, and offers of employment have been accepted by four further team members: a Business Development Director for Translogik, and three experienced engineering and project management professionals, to support the delivery of new projects and industrialisation activity in SAWsense. The Company is also hiring a dedicated marketing lead to support the business development teams across both divisions. These new members of the team will be joining early in the new year with a full workload.

As well as supporting a growing blue-chip customer base, R&D activity in the Period has led to significant progress towards industrialisation of the SAWsense technology. This meets the objective of being able to better support customers by demonstrating a clear pathway to scale-up manufacturing, as well as improving low volume production capacity and capability. Transense has also expanded functionality and delivered enhancements to the Translogik product in response to customer requests that will open up new market potential. This R&D activity has also led to the Company making its first new patent applications in ten years, significantly extending the SAWsense IP base. Details of these new patents will be released in due course.

Transense signed an MOU last year with Meggitt SA, with the joint aim of concluding a licence for SAW technology in the aerospace sector by 31 December 2023. The acquisition of Meggitt by Parker since then opens up new potential to expand the current working relationship between both parties, but the resulting organisational changes within their business have impacted their ability to progress licence discussions. Whilst the pace of progress has been measured, the Board continues to value the relationship with Parker Meggitt. Transense does not expect to conclude a licence by 31 December and will provide further updates in due course.

 

Independently, Transense has made excellent progress in the broader aerospace market, where the Company is now engaged directly with a number of additional engine and air frame manufacturers.

Since the announcement of a £0.65m share buyback programme on 27 September 2022, the Company has acquired 528,000 shares to be held in treasury at a total cost of £0.47m. The remainder of £0.18m is available for further such purchases, subject to shareholder approval at today's AGM. The Board may announce a further programme during the year if this is considered appropriate.

The Board is pleased with the momentum in the ongoing commercial pipeline, both for SAWsense and Translogik, which provides confidence in the prospects for the current financial year and beyond.

Online access to the AGM

Shareholders who wish to view the AGM remotely should register for the event in advance via the following link: 

https:www.investormeetcompany.com/transense-technologies-plc/register-investor

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/George Payne (Corporate Finance)

Stefano Aquilino / Tony Quirke (Sales & Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Joe Walker

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

Notes to Editors:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, automotive (high performance and off-road) and complex machine control.

 

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

 

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

 

For further information please contact transense@walbrookpr.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMPPGWGGUPWPPR
Date   Source Headline
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company
28th Sep 20235:22 pmRNSHolding(s) in Company
27th Sep 20233:18 pmRNSHolding(s) in Company
26th Sep 20233:37 pmRNSDirector/PDMR Shareholding
25th Sep 202311:00 amRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSFinal Results & Investor Presentation
22nd Sep 20239:25 amRNSHolding(s) in Company
31st Aug 20235:00 pmRNSTotal Voting Rights
29th Aug 20238:30 amRNSTransaction in Own Shares & TVR
23rd Aug 20237:00 amRNSNotice of Results & Investor Presentation
16th Aug 202310:03 amRNSHolding(s) in Company
11th Jul 20237:00 amRNSYear End Trading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20234:24 pmRNSTransaction in own shares & TVR
19th Jun 20234:29 pmRNSHolding(s) in Company
16th Jun 20235:57 pmRNSTransaction in own shares & TVR
5th Jun 20237:00 amRNSSAW: Extension of scope of licence agreement
2nd Jun 20232:36 pmRNSTransaction in own shares & TVR
31st May 20235:00 pmRNSTotal Voting Rights
3rd May 20237:00 amRNSNew Automotive eDrive Business Contract
2nd May 202312:48 pmRNSAppointment of Non-Executive Director
2nd May 202310:23 amRNSTransaction in own shares & TVR
31st Mar 20235:00 pmRNSTotal Voting Rights
27th Mar 20237:00 amRNSGrant of share options to Director and employees
20th Mar 20238:49 amRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.